Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis

Digestive Diseases and Sciences

Volumn 45, Issue 10, 2000, Pages 1971-1976

  Karasu, Zeki ^a,b   Gurakar, Ahmet ^a,b   Kerwin, Barbara ^a,b   Hulagu, Saadettin ^a,b   Jazzar, Ahmad ^a,b   Mcfadden, Robert ^a,b   Nour, Bakr ^a,b   Sebastian, Anthony ^a,b   Cassidy, Francis ^a,b   Stokes, Kenneth ^a,b   Van Thiel, David ^b   Wright, Harlan ^a,b  

^a INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Platelet; Platelet volume; Thrombocytopenia; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; SURGICAL APPROACH; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOCYTOPENIA;

ADULT; AGED; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0033732227     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005694617983     Document Type: Article

References (56)

1. Association of cirrhosis, thrombocytopenia and hemorrhagic tendency
2. The effect of portocaval shunt on hypersplenism
3. Effect of operations for variceal hemorrhage on hypersplenism
4. Portal hypertension, congestive splenomegaly, and portocaval shunt
5. Effect of portocaval anastamosis on hypersplenism
6. The effect of the distal splenorenal shunt on hypersplenism
7. Thrombocytopenie und lebercirrhose
8. The pathogenesis of splenomegaly in hypertension of the portal circulation: 'Congestive splenomegaly'
9. Peripheral blood picture after operation for portal hypertension
10. Results of a modified distal spleno-renal shunt for portal hypertension
11. The effect of portocaval shunt on thrombocytopenia associated with portal hypertension
12. Lateral portocaval anastomosis for portal hypertension
13. Effect of portasystemic shunt on hypersplenism. Clinical study in 129 patients with cirrhosis
14. Correction of hypersplenism following distal splenorenal shunt
15. Portasystemic venous shunts
16. Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism
17. Reversal of hypersplenism following orthotopic liver transplantation
18. Platelet changes following clinical and experimental hepatic homotransplantation
19. Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension?
20. Size dependent platelet subpopulations: Relationship of platelet volume to ultrastructure, enzymatic activity and function
21. The inverse relation between platelet volume and platelet number. Abnormalities in haematologic disease and evidence that platelet size does not correlate with platelet age
22. Hypersplenic thrombocytopenia differentiated from increased peripheral destruction by platelet volume
23. Megakaryocytes and platelets in vascular disease
24. Transjugular intrahepatic portal-systemic shunts: The state of the art
25. The transjugular intrahepatic portosystemic stent-shunt for variceal bleeding
26. Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: Experience in candidate and noncandidate patient for liver transplantation
27. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: Results in 100 patients
28. TIPS as a bridge to OLTx for patients with variceal hemorrhage and/or refractory ascites
29. Pooling of platelets in the spleen: Role in the pathogenesis of 'hypersplenic' thrombocytopenia
30. Kinetics, distribution and sites of destruction of 111-indium-labelled human platelets
31. Use of 111-indium-labelled platelets to measure spleen function
32. Factors controlling the intrasplenic transit of platelets
33. Splenic blood flow and intrasplenic platelet kinetics in relation to spleen volume
34. Splenic blood flow and blood cell kinetics
35. Kinetics, in vivo redistribution and sites of sequestration of indium-111-labelled platelets in giant platelet syndromes
36. The hematologic consequences of transjugular intrahepatic portosystemic shunts
37. Splenomegaly and hypersplenism
38. Increased splenic pooling and the pathogenesis of hypersplenism
39. Hypersplenism and portal hypertension
40. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis
41. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients
42. The routine measurement of platelet size using sodium citrate alone as the anticoagulant
43. Evidence that spleen retains youngest and haemostatically most effective platelets
44. The influence of traumatic splenectomy on the volume of human platelets
45. Influence of splenectomy on platelet morphometry and function
46. Role of the liver in controlling the immunogenicity of commensal bacteria in the gut
47. Hyperglobulinemia in liver disease
48. Platelet-associated IgG in acute and chronic hepatic diseases
49. Interrelationships between platelet count, platelet IgG, serum IgG, immun-complexes and severity of liver disease
50. Immune thrombocytopenia and response to splenectomy in chronic liver disease
51. Hemostasis in advanced liver disease
52. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization
53. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation
54. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver
55. Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis
56. Direct evidence for an increase in thrombopoiesis after liver transplantation